Delivery Order SPE2DB20D1100-SPE2DB25FB0L8

Award Date 3/10/25
Potential Completion Date 3/11/25
Potential Value $4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of WEGOVY 2.4 MG/0.75 ML PEN 0.75ML, a medical product, with a ceiling value of $1,541.54 and a period of performance through January 28, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of WEGOVY 0.5 MG/0.5 ML PEN 0.5ML, a medical product, with a ceiling value of $7,650.20 and a completion date of March 7, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of WEGOVY 1 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, with a ceiling value of $1,228.50 and a completion date of February 4, 2025. The contract is a Firm Fixed Price Delivery Order with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $24,407.23, is for the delivery of WEGOVY 0.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and has an ultimate completion date of December 18, 2024. It is not designated as a set-aside contract. AmerisourceBergen Drug Corp...
This is a $14,570.01 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the provision of WEGOVY 0.5 MG/0.5 ML PEN 0.5ML, a medical product, with a period of performance through May 15, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of WEGOVY 1 MG/0.5 ML PEN 0.5ML, a medical product, with a total ceiling value of $12,149.99. The contract is a Delivery Order with a Firm Fixed Price pricing type, and it has an ultimate completion date of February 25, 2025. The contract is not designated as a set-aside. AmerisourceBergen...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of WEGOVY 0.25 MG/0.5 ML PEN 0.5ML, a medical product, with a ceiling value of $12,392.68 and a period of performance ending on November 14, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type, and there is no set-aside designation. AmerisourceBergen Drug Corp holds a...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of WEGOVY 2.4 MG/0.75 ML PEN 0.75ML, a medical product, with a ceiling value of $5,979.47 and an ultimate completion date of December 27, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of WEGOVY 1 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, with a total ceiling value of $6,812.98 and a period of performance through February 18, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation indicated. AmerisourceBergen Drug Corp holds a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of WEGOVY 1.7 MG/0.75 ML PEN 0.75ML, a pharmaceutical product. The contract has a ceiling value of $4,336.58 and a completion date of March 5, 2025. It is a firm fixed-price delivery order contract with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB25FB0L8
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of WEGOVY 0.5 MG/0.5 ML PEN 0.5ML, a medical product, with a ceiling value of $4,012.40 and a period of performance through March 11, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 6/9/25, 9:52 AM